Universe pharmaceuticals inc
UPC 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
價值面評分低，若以價值投資為目標且有長期投資部位，需要嚴格執行自己的出場計畫來減持部位
UPC 近期報酬表現
-5.48%
Universe pharmaceuticals inc
-0.89%
同產業平均
-0.88%
S&P500
與 UPC 同產業的標的表現
| 股票代碼 | 公司名稱 | 價值 | 趨勢 | 波段 | 籌碼 | 股利 | 加入追蹤 |
|---|---|---|---|---|---|---|---|
URGN | Urogen pharma ltd | 3 分 | 3 分 | 2 分 | 3 分 | 1 分 | |
ARMP | Armata pharmaceuticals inc | 5 分 | 3 分 | 2 分 | 1 分 | 1 分 | |
BLTE | Belite bio inc - adr | - | 1 分 | 2 分 | 1 分 | 1 分 | |
EOLS | Evolus inc | 4 分 | 2 分 | 2 分 | 3 分 | 1 分 | |
TLRY | Tilray brands inc | 2 分 | 3 分 | 1 分 | 1 分 | 1 分 |
- URGN Urogen pharma ltd價值 3 分趨勢 3 分波段 2 分籌碼 3 分股利 1 分查看更多
UPC 公司資訊
Universe Pharmaceuticals Inc. Universe Pharmaceuticals Inc is a China-based holding company mainly engaged in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (TCMD) products targeting the elderly. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The Company mainly conducts its businesses within the Chinese market.